Aflac Incorporated (NYSE:AFL) Stock Holdings Trimmed by Concurrent Investment Advisors LLC

Concurrent Investment Advisors LLC decreased its holdings in Aflac Incorporated (NYSE:AFL) by 10.7% in the 1st quarter, HoldingsChannel reports. The firm owned 30,134 shares of the financial services provider’s stock after selling 3,623 shares during the quarter. Concurrent Investment Advisors LLC’s holdings in Aflac were worth $2,587,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Flputnam Investment Management Co. raised its stake in shares of Aflac by 0.5% in the 4th quarter. Flputnam Investment Management Co. now owns 25,031 shares of the financial services provider’s stock valued at $2,065,000 after purchasing an additional 122 shares during the period. ICA Group Wealth Management LLC increased its stake in Aflac by 4.3% in the 4th quarter. ICA Group Wealth Management LLC now owns 2,974 shares of the financial services provider’s stock valued at $245,000 after buying an additional 122 shares during the last quarter. TKG Advisors LLC boosted its stake in shares of Aflac by 0.5% during the 1st quarter. TKG Advisors LLC now owns 24,536 shares of the financial services provider’s stock worth $2,107,000 after buying an additional 122 shares during the last quarter. PDS Planning Inc grew its holdings in shares of Aflac by 4.7% in the 1st quarter. PDS Planning Inc now owns 2,761 shares of the financial services provider’s stock valued at $237,000 after acquiring an additional 125 shares in the last quarter. Finally, Simon Quick Advisors LLC raised its holdings in Aflac by 4.9% during the fourth quarter. Simon Quick Advisors LLC now owns 2,950 shares of the financial services provider’s stock worth $243,000 after acquiring an additional 139 shares in the last quarter. 67.44% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Aflac

In related news, Director Charles D. Lake II sold 22,378 shares of Aflac stock in a transaction that occurred on Tuesday, May 21st. The shares were sold at an average price of $87.47, for a total value of $1,957,403.66. Following the completion of the transaction, the director now directly owns 61,522 shares in the company, valued at approximately $5,381,329.34. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Aflac news, Director Charles D. Lake II sold 22,378 shares of the company’s stock in a transaction dated Tuesday, May 21st. The shares were sold at an average price of $87.47, for a total transaction of $1,957,403.66. Following the completion of the sale, the director now directly owns 61,522 shares in the company, valued at $5,381,329.34. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Joseph L. Moskowitz sold 600 shares of the firm’s stock in a transaction on Wednesday, May 8th. The stock was sold at an average price of $84.84, for a total transaction of $50,904.00. Following the completion of the sale, the director now directly owns 27,550 shares in the company, valued at approximately $2,337,342. The disclosure for this sale can be found here. Corporate insiders own 0.90% of the company’s stock.

Aflac Trading Up 0.7 %

NYSE AFL traded up $0.65 during trading hours on Monday, reaching $93.29. The company’s stock had a trading volume of 998,983 shares, compared to its average volume of 2,203,552. The stock has a market cap of $53.01 billion, a P/E ratio of 10.26, a P/E/G ratio of 2.53 and a beta of 0.95. The firm has a fifty day simple moving average of $88.22 and a 200-day simple moving average of $84.42. The company has a debt-to-equity ratio of 0.34, a current ratio of 0.08 and a quick ratio of 0.08. Aflac Incorporated has a 52 week low of $69.00 and a 52 week high of $93.86.

Aflac (NYSE:AFL) last announced its quarterly earnings data on Monday, May 6th. The financial services provider reported $1.66 earnings per share for the quarter, beating the consensus estimate of $1.58 by $0.08. Aflac had a net margin of 27.67% and a return on equity of 16.88%. The firm had revenue of $5.44 billion for the quarter, compared to analyst estimates of $4.09 billion. During the same quarter in the prior year, the business earned $1.55 earnings per share. The business’s quarterly revenue was up 13.3% compared to the same quarter last year. Equities analysts forecast that Aflac Incorporated will post 6.44 earnings per share for the current fiscal year.

Aflac Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, June 3rd. Investors of record on Wednesday, May 22nd were issued a dividend of $0.50 per share. This is a positive change from Aflac’s previous quarterly dividend of $0.42. This represents a $2.00 dividend on an annualized basis and a yield of 2.14%. The ex-dividend date was Tuesday, May 21st. Aflac’s dividend payout ratio (DPR) is 22.08%.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. Truist Financial boosted their target price on shares of Aflac from $80.00 to $82.00 and gave the stock a “hold” rating in a report on Friday, May 3rd. Wells Fargo & Company raised their target price on shares of Aflac from $81.00 to $82.00 and gave the company an “equal weight” rating in a research note on Friday, May 10th. Bank of America boosted their price target on Aflac from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Thursday. JPMorgan Chase & Co. boosted their target price on Aflac from $80.00 to $83.00 and gave the stock a “neutral” rating in a report on Tuesday, July 2nd. Finally, Morgan Stanley raised their price target on Aflac from $80.00 to $84.00 and gave the company an “equal weight” rating in a report on Monday, April 15th. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $85.15.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.